Potential anticoagulant of traditional chinese medicine and novel targets for anticoagulant drugs

Background: Anticoagulants are the main drugs used for the prevention and treatment of thrombosis. Currently, anticoagulant drugs are primarily multitarget heparin drugs, single-target FXa inhibitors and FIIa inhibitors. In addition, some traditional Chinese drugs also have anticoagulant effects, but they are not the main direction of treatment at present. But the anticoagulant drugs mentioned above, all have a common side effect is bleeding. Many other anticoagulation targets are under investigation. With further exploration of coagulation mechanism, how to further determine new anticoagulant targets and how to make traditional Chinese medicine play anti-coagulant role have become a new field of exploration. Purpose: The purpose of the study was to summarize the recent research progress on coagulation mechanisms, new anticoagulant targets and traditional Chinese medicine. Methods: A comprehensive literature search was conducted using four electronic databases, including PubMed, Embase, CNKI, Wanfang database and ClinicalTrials.gov, from the inception of the study to 28 Feb 2023. Key words used in the literature search were anticoagulation, anticoagulant targets, new targets, coagulation mechanisms, potential anticoagulant, herb medicine, botanical medicine, Chinese medicine, tradi-tional Chinese medicine, blood coagulation factor, keywords are linked with AND/OR. Recent findings on coagulation mechanisms, potential anticoagulant targets and traditional Chinese medicine were studied. Results: The active components extracted from the Chinese medicinal herbs, Salvia miltiorrhiza, Chuanxiong rhizoma, safflower and Panax notoginseng have obvious anticoagulant effects and can be used as potential anticoagulant drugs, but the risk of bleeding is unclear. TF/FVIIa, FVIII, FIX, FXI, FXII, and FXIII have all been evaluated as targets in animal studies or clinical trials. FIX and FXI are the most studied anticoagulant targets, but FXI inhibitors have shown stronger advantages. Conclusion: This review of potential anticoagulants provides a comprehensive resource. Literature analysis suggests that FXI inhibitors can be used as potential anticoagulant candidates. In addition, we should not ignore the anticoagulant effect of traditional Chinese medicine, and look forward to more research and the emergence of new drugs.

Automated summary

This study aims to summarize the recent research progress on coagulation mechanisms, new anticoagulant targets, and traditional Chinese medicine. Through literature review, it is found that active components extracted from Chinese medicinal herbs, including Salvia miltiorrhiza, Chuanxiong rhizoma, safflower, and Panax notoginseng, have significant anticoagulant effects and can be potential anticoagulant drugs, but the risk of bleeding is unclear. TF/FVIIa, FVIII, FIX, FXI, FXII, and FXIII have all been evaluated as targets in animal studies or clinical trials. Among them, FXI inhibitors have shown stronger advantages. In conclusion, this review provides a comprehensive resource for potential anticoagulants, and FXI inhibitors can be considered as potential anticoagulant candidates. The anticoagulant effect of traditional Chinese medicine should not be ignored, and more research and new drugs are expected.